Zentalis Pharmaceuticals Llc share price logo

Zentalis Pharmaceuticals Llc

NASDAQ: ZNTL

Small Cap

$4.25

+0.07

(+1.67%)

Live

as on

Zentalis Pharmaceuticals Llc Stock Performance

as on May 8, 2026 at 3:12 am IST

  • Day's Low

    Day's High

    $4.11
    $4.32
    downward going graph

    3.29%

    Downside

    1.65%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.13
    $6.95
    downward going graph

    73.41%

    Downside

    63.53%

    Upside

    downward going graph

Zentalis Pharmaceuticals Llc share price movements today

Previous Close
$4.18
Open
$4.15
Volume
336.0K
Day's Low - High
$4.11 - $4.32
52 Week Low - High
$1.13 - $6.95

Zentalis Pharmaceuticals Llc Historical Returns

1 Month Return
+ 56.55 %
3 Month Return
+ 74.9 %
1 Year Return
+ 239.84 %
3 Year Return
-81.25 %
5 Year Return
-92.94 %

Zentalis Pharmaceuticals Llc Stock Fundamentals & Key Indicators

Check Zentalis Pharmaceuticals Llc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$291.2M

EPS (TTM)

-1.77

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-140.1M

Revenue (TTM)

26.9M

Profit Margin

0.00%

Return On Equity TTM

-49.54%

Zentalis Pharmaceuticals Llc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zentalis Pharmaceuticals Llc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Zentalis Pharmaceuticals Llc image
Zentalis Pharmaceuticals Llc
BUY$291.2M-92.94%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.5B130.77%76.3212.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.5BNA70.895.37%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$108.5B98.9%25.3835.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$75.6B45.15%17.629.65%

Stock Returns calculator for Zentalis Pharmaceuticals Llc Stock including INR - Dollar returns

The Zentalis Pharmaceuticals Llc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Zentalis Pharmaceuticals Llc investment value today

Current value as on today

₹3,84,349

Returns

₹2,84,349

(+284.35%)

Returns from Zentalis Pharmaceuticals Llc Stock

₹2,45,528 (+245.53%)

Dollar Impact

₹38,820 (+38.82%)

Analyst Recommendation on Zentalis Pharmaceuticals Llc Stock

Based on 17 analysts

BUY

82.35%

Buy

17.65%

Hold

0.00%

Sell

Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Zentalis Pharmaceuticals Llc. Average target price of $6.25

Zentalis Pharmaceuticals Llc Share Price Target

Get share price movements and forecasts by analysts on Zentalis Pharmaceuticals Llc.

What analysts predicted

32%UPSIDE

Target Price

$6.25

Current Price

$4.25

Analyzed by

17 Analysts

Target

$6.25

Zentalis Pharmaceuticals Llc target price $6.25, a slight upside of 32% compared to current price of $4.25. According to 17 analysts rating.

Indian Investors' Interest in Zentalis Pharmaceuticals Llc Stock

Search interest for Zentalis Pharmaceuticals Llc Stock has increased by 873% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:873% versus previous 30 day period

Zentalis Pharmaceuticals Llc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
2
40
-
-
26
-
-
-
-
Gross Profit
0
1
40
0
0
26
0
0
-
0
Operating Income
-62
-67
-24
-65
-51
-49
-45
-36
-33
-37
EBITDA
-62
-67
-24
-64
-51
-45
-37
-34
-26
-37
Interest Expense
-
5
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-55
-61
10
-88
-40
-47
-48
-26
-26
-34
Income Tax Expense
0
0
0
0
0
0
-
-
-
0
Net Income
-55
-60
10
-88
-40
-47
-48
-26
-26
-35
Net Profit Margin
0.00%
-2895.29%
24.82%
0.00%
0.00%
-176.71%
0.00%
0.00%
0.00%
0.00%

Zentalis Pharmaceuticals Llc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
-
-
-
-
67
-
Gross Profit
0
0
0
0
-1
-1
67
0
Operating Income
-23
-46
-118
-216
-227
-299
-191
-146
EBITDA
-23
-46
-118
-207
-225
-247
-186
-145
Interest Expense
-
1
2
110
2
-
-
-
Depreciation
0
0
0
0
1
1
1
0
Income Before Tax
-23
-46
-118
-166
-237
-292
-165
-136
Income Tax Expense
0
0
0
0
0
0
0
0
Net Income
-21
-45
-117
-158
-236
-292
-165
-137
Net Profit Margin
-150478.57%
0.00%
0.00%
0.00%
0.00%
0.00%
-245.96%
0.00%

Zentalis Pharmaceuticals Llc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-60
10
-88
-40
-47
-48
-26
-26
-35
Operating Cash Flow
-40
-51
-35
-44
-39
-32
-34
-26
-30
Investing Cash Flow
-42
61
34
48
32
40
30
28
32
Financing Cash Flow
-
0
0
0
-
0
-
0
-4
Change in Cash
-82
9
0
4
-7
8
-4
1
-3

Zentalis Pharmaceuticals Llc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-46
-118
-166
-237
-292
-165
-137
Operating Cash Flow
-39
-86
-154
-163
-207
-170
-125
Investing Cash Flow
0
-284
-18
-114
-44
176
131
Financing Cash Flow
81
360
178
261
237
0
-4
Change in Cash
42
-11
6
-16
-14
5
2

Global Institutional Holdings in Zentalis Pharmaceuticals Llc

Funds
Holdings
Connor Clark & Lunn Inv Mgmt Ltd
1.11%
Matrix Capital Management Company, LLC
21.56%
Geode Capital Management, LLC
0.83%
Tybourne Capital Management (HK) Ltd
1.36%
Acadian Asset Management LLC
4.39%
See all

Insights on Zentalis Pharmaceuticals Llc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ZNTL stock has moved up by 56.6%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ZNTL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 106.6%

About Zentalis Pharmaceuticals Llc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. The company also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is based in San Diego, California.
OrganisationZentalis Pharmaceuticals Llc
Headquarters10275 Science Center Dr., San Diego, CA, United States, 92121
IndustryBiotechnology
CEOMs. Julie M. Eastland M.B.A.
E-voting on sharesClick here to vote

Key Management of Zentalis Pharmaceuticals Llc

Name

Title

Ms. Julie M. Eastland M.B.A.

CEO, President & Director

Mr. Haibo Wang

Chief Business Officer

Mr. Rajesh Israni

Executive VP of Regulatory Affairs & Medical Writing

Mr. Henry Gu

Senior VP & Head of Intellectual Property

FAQs

What is Zentalis Pharmaceuticals Llc share price today?

Zentalis Pharmaceuticals Llc share price today is $4.25 as on . Zentalis Pharmaceuticals Llc share today touched a day high of $4.32 and a low of $4.11.

What is the 52 week high and 52 week low for Zentalis Pharmaceuticals Llc share?

Zentalis Pharmaceuticals Llc share touched a 52 week high of $6.95 on and a 52 week low of $1.13 on . Zentalis Pharmaceuticals Llc stock price today i.e. is trending at $4.25,which is 38.85% down from its 52 week high and 276.11% up from its 52 week low.

What is Zentalis Pharmaceuticals Llc's market capitalisation today?

Zentalis Pharmaceuticals Llc market capitalisation is $0.00T as on .

How to invest in Zentalis Pharmaceuticals Llc Stock (ZNTL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zentalis Pharmaceuticals Llc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zentalis Pharmaceuticals Llc Shares that will get you 0.3529 shares as per Zentalis Pharmaceuticals Llc share price of $4.25 per share as on May 7, 2026 at 9:42 pm IST.

What is the minimum amount required to buy Zentalis Pharmaceuticals Llc Stock (ZNTL) from India?

Indian investors can start investing in Zentalis Pharmaceuticals Llc (ZNTL) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Zentalis Pharmaceuticals Llc stock (as per the Rupee-Dollar exchange rate as on ). Based on Zentalis Pharmaceuticals Llc share’s latest price of $4.25 as on May 7, 2026 at 9:42 pm IST, you will get 2.3529 shares of Zentalis Pharmaceuticals Llc. Learn more about fractional shares .

What are the returns that Zentalis Pharmaceuticals Llc has given to Indian investors in the last 5 years?

Zentalis Pharmaceuticals Llc stock has given -92.94% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?